Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma

References

• Batani P, Brugere J, Bernier J, Jaulerny CH, Picot G, Ghossein NA. Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus: experience of Institut Curie. Int J Radiat Oncol Biol Phys 1982; 8: 1277–86
   PubMed Web of Science ®Google Scholar
• Chang L, Stevens KR, Moss WT, Marquez CM, Pearse HD, Cohen JI. Squamous cell carcinoma of the pharyngeal walls treated with radiotherapy. Int J Radiat Oncol Biol Phys 1996; 35: 477–83
   PubMed Web of Science ®Google Scholar
• Hull MC, Morris CG, Tannehill SP, Werning JW, Amdur RJ, Hinerman RW, et al. Definitive radiotherapy alone or combined with a planned neck dissection for squamous cell carcinoma of the pharyngeal wall. Cancer 2003; 98: 2224–31
   PubMed Web of Science ®Google Scholar
• Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma: treatment results in 138 consecutively admitted patients. Acta Oncol 2000; 39: 529–36
   PubMed Web of Science ®Google Scholar
• Bova R, Goh R, Poulson M, Coman WP. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope 2005; 115: 864–9
   PubMed Web of Science ®Google Scholar
• Sewnaik A, Hoorweg JJ, Knegt PP, Wieringa MH, van der Beek JM, Kerrebijn JD. Treatment of hypopharyngeal carcinoma: analysis of nation-wide study in the Netherlands over a 10-year period. Clin Otolaryngol 2005; 30: 52–7
   PubMed Web of Science ®Google Scholar
• Won Taek Kim, Yong Kan Ki, Ji Ho Nam, Dong Won Kim, Byung Ju Lee, Su Gun Wang, et al. The results of postoperative radiotherapy for hypopharyngeal carcinoma. J Kor Soc Thera Radiol Oncol 2004; 22: 254–64
   Google Scholar
• Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000; 355: 949–55
   PubMed Web of Science ®Google Scholar
• Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091–8
   PubMed Web of Science ®Google Scholar
• Taylor SG, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994; 12: 385–95
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier PI. A nonparametric estimation from incomplete observation. J Am Statis Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology (RTOG) and the European Organization for the Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341–6
   PubMed Web of Science ®Google Scholar
• Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47: 13–47
   PubMed Web of Science ®Google Scholar
• The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685–90.
   PubMed Web of Science ®Google Scholar
• Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmaud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. J Natl Cancer Inst 1996; 88: 890–5
   PubMed Web of Science ®Google Scholar
• Niibe Y, Karasawa K, Mitsuhashi T, Tanaka Y. Hyperfractionated radiation therapy for hypopharygeal carcinoma compared with conventional radiation: local control, laryngeal preservation and overall survival. Jpn J Clin Oncol 2003; 33: 450–5
   PubMed Web of Science ®Google Scholar
• Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7–16
   PubMed Web of Science ®Google Scholar
• Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798–804
   PubMed Web of Science ®Google Scholar
• Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Nagovic A, Aleksandrovic J, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000; 18: 1458–64
   PubMed Web of Science ®Google Scholar
• Bensadoun RJ, Bénézery K, Dassonville O, Magné N, Poissonnet G, Ramaïoli A, et al. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys 2006; 64: 983–94
   PubMed Web of Science ®Google Scholar
• Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, et al. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol 2004; 22: 3061–9
   PubMed Web of Science ®Google Scholar
• Urba SG, Moon J, Giri PG, Adelstein DJ, Hanna E, Yoo GH, et al. Organ preservation for advanced laryngeal resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group trial. J Clin Oncol 2005; 23: 88–95
   PubMed Web of Science ®Google Scholar
• Vermorken J, Remenar E, van Herpen C, Germa Lluch J, Stewart S, Gorlia M. Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC#24971). Proc Am Soc Clin Oncol 2004;22(14S):490 ( abstract 5508).
   Google Scholar